Evaluation and Disruption of Tau - GSK3β Vicious Cycle
Evaluation and Disruption of Tau - GSK3β Vicious Cycle
批准号:
10398663
负责人:
Daniel Gulbranson
金额:
$0.25万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2022-08-31
关键词:
AdultAdverse effectsAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAntisense OligonucleotidesAxonal TransportBindingBlood - brain barrier anatomyBrainCellsDataDevelopmentDiseaseDisease ProgressionDoseEnterobacteria phage P1 Cre recombinaseEvaluationExcisionExposure toGoalsHumanImmuneImpaired cognitionKnockout MiceLeadLearningMaintenanceMediatingMemoryMemory impairmentModelingMusNerve DegenerationNeurogliaNeuronsPathogenesisPathogenicityPathway interactionsPenetrationPhosphotransferasesPreclinical TestingProcessProtein KinaseProteinsSafetySignal TransductionTauopathiesTestingTherapeuticTransgenic OrganismsViral Vectorexcitatory neuronexcitotoxicityexperimental studyin vivomouse modelmutantneuron lossneuronal survivaloffspringpreventpromoterprotein kinase inhibitorrhotau Proteinstau expressiontau mutation
中文摘要
项目总结/摘要
我们的目标是提高我们对阿尔茨海默病的理解和治疗能力。我们的实验室发现,
减少可以防止A β诱导的GSK 3 β激活,GSK 3 β是一种由许多AD相关的
病理机制,并与tau蛋白的过度磷酸化有关。我们将决定
这些机制以tau依赖的方式激活GSK 3 β,并且激活是否涉及直接的
tau和GSK 3 β之间的相互作用。为了防止tau依赖性GSK 3 β激活,我们建议减少
总体tau水平。Tau减少可以预防AD小鼠模型中的认知下降和神经变性。
我们发现,阻断rho相关蛋白激酶(ROCK)通路可以降低原代细胞中的tau蛋白水平。
和成年小鼠脑中。为了进一步探索这种治疗策略,我们将使用一种新的ROCK抑制剂,
在小鼠模型中具有高效力和良好的脑渗透性。
英文摘要
Project Summary/Abstract
Our goal is to advance our understanding and ability to treat Alzheimer's disease. Our lab discovered that tau
reduction can prevent A-induced activation of GSK3, a kinase that is activated by many AD-relevant
pathomechanisms and has been implicated in the hyperphosphorylation of tau. We will determine which of
these mechanisms activate GSK3β in a tau-dependent manner and whether the activation involves direct
interactions between tau and GSK3β. To prevent tau-dependent GSK3 activation, we propose to reduce
overall tau levels. Tau reduction can prevent cognitive decline and neurodegeneration in mouse models of AD.
We found that blocking the rho-associated protein kinase (ROCK) pathway reduces tau levels in primary cells
and in adult mouse brain. To further explore this therapeutic strategy, we will use a new ROCK inhibitor that
has high potency and good brain penetration in mouse models.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Generating Custom Pooled CRISPR Libraries for Genetic Dissection of Biological Pathways.
生成用于生物途径遗传解析的定制 CRISPR 文库。
DOI:
10.1007/978-1-0716-2209-4_21
发表时间:
2022
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Gulbranson,DanielR]
通讯作者:
Gulbranson,DanielR
Evaluation and Disruption of Tau - GSK3ò Vicious Cycle
-
批准号:10237411
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2019
-
负责人:Daniel Gulbranson
-
依托单位:
Evaluation and Disruption of Tau - GSK3β Vicious Cycle
-
批准号:10075784
-
项目类别:
-
资助金额:$6.74万
-
财政年份:2019
-
负责人:Daniel Gulbranson
-
依托单位:
海外基金